THE PRESENT INVENTION PROVIDES METHODS AND COMPOSITIONS (SUCH AS PHARMACEUTICAL COMPOSITIONS) COMPRISING PAR1 ANTAGONISTS FOR TREATING OR PREVENTING INFLUENZA VIRUS TYPE A INFECTIONS IN PARTICULAR H1N1 INFECTION. PAR1 ANTAGONISTS MAY BE COMBINED WITH A PAR2 AGONIST.